Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Cash-From-Operating-Activities" stands at 24.20 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Johnson & Johnson's third quarter result of 9.17 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 136.44 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of 9.17 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 14.71 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 24.20 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 5.11 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -3.75 percent compared to the value the year prior.
The 1 year change in percent is -3.75.
The 3 year change in percent is 12.18.
The 5 year change in percent is 12.10.
The 10 year change in percent is 30.40.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Cash From Operating Activities | 905,699,262,464.00 |
![]() | AbbVie Inc - Total Cash From Operating Activities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Cash From Operating Activities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Cash From Operating Activities | 280,205,508,085.11 |
![]() | Novartis AG - Total Cash From Operating Activities | 255,096,620,580.91 |